1. Ficolin-3 may act as a tumour suppressor by recognising O-GlcNAcylation site in hepatocellular carcinoma. (September 2022) Authors: Luo, Jiamei; Wang, Teng; Wang, Xiaoqiang; Shi, Yumiao; Zhang, Yiqi; Tian, Jie; Gong, Yin Journal: Medical hypotheses Issue: Volume 166(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Successive treatment with naltrexone induces epithelial–mesenchymal transition and facilitates the malignant biological behaviors of bladder cancer cells. (7th January 2021) Authors: Wang, Xiaoqiang; Zhang, Ruirui; Wu, Tong; Shi, Yumiao; Zhou, Xiao; Tang, Dan; Yu, Weifeng; So, Edmund Cheung; Wu, Xiaodan; Pan, Zhiying; Tian, Jie Journal: Acta biochimica et biophysica Sinica Issue: Volume 53:Number 2(2021) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The kappa opioid receptor may be a potential tumor suppressor by regulating angiogenesis in breast cancer. (May 2021) Authors: Shi, Yumiao; Luo, Jiamei; Tian, Jie; Zou, Qiaoqun; Wang, Xiaoqiang Journal: Medical hypotheses Issue: Volume 150(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial. Issue 3 (5th February 2023) Authors: Wang, Xiaoqiang; Zhang, Song; Jin, Di; Luo, Jiamei; Shi, Yumiao; Zhang, Yiqi; Wu, Lingling; Song, Yanling; Su, Diansan; Pan, Zhiying; Chen, Haige; Cao, Ming; Yang, Chaoyong; Yu, Weifeng; Tian, Jie Journal: Cancer communications Issue: Volume 43:Issue 3(2023) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗